SCX.ai (ASX: SCX) — Canaccord Genuity initiation, A$0.80 price target

Preview text: SCX.ai (ASX: SCX) — Canaccord Genuity initiation, A$0.80 price target 96 SCX.ai (ASX: SCX)…

Monday, Sep 14, 2026 at 4:30 AM EasternHubSpot

SharewiseSCX.ai (ASX: SCX) — Canaccord Genuity initiation, A$0.80 price target

Fit to screenFull size

Using this email in an article? Credit: Sharewise email via They Sent It, with a link to this page. Full-size image

Use this example

Subject: SCX.ai (ASX: SCX) — Canaccord Genuity initiation, A$0.80 price target
Preview text: SCX.ai (ASX: SCX) — Canaccord Genuity initiation, A$0.80 price target 96 SCX.ai (ASX: SCX)…
From: enquiries@sharewise.com.au
Brand: Sharewise
ESP: HubSpot
Sent: Mon Sep 14, 2026, 4:30 AM ET
Size: 59 KB
Images: 9
Links: 14, 2 of them buttons
Subject length: 69 characters

Against Sharewise's usual

Sent in the 4 AM hour, which holds 2% of its emails; 17% arrive in the 9 PM hour. The subject is 69 characters; its average is 56.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: Sharewise <[email protected]>
Reply-To: [email protected]
Subject: SCX.ai (ASX: SCX) — Canaccord Genuity initiation, A$0.80 price target
Date: Mon, 14 Sep 2026 18:30:34 +1000
Message-ID domain: bf05x.hubspotemail.net
Return-Path domain: bf05x.hubspotemail.net
DKIM signature: d=bf05x.hubspotemail.net s=hs1; d=sharewise.com.au s=hs2-24076189
List-Unsubscribe: Present, one-click
Feedback-ID sender: HubSpot

Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To

	Sep 18, 2026 1:28 AM	Join Our Webinar with RareX CEO James Durrant!
	Sep 15, 2026 10:06 PM	Join Our Webinar with Dimerix's Dr Nina Webster!
	Sep 14, 2026 6:36 PM	4DMedical (ASX:4DX, Valuation A$5.3/shr - upgraded) - Owning the Ecosystem
	Sep 14, 2026 4:30 AM	SCX.ai (ASX: SCX) — Canaccord Genuity initiation, A$0.80 price target (this email)
	Sep 10, 2026 10:07 PM	TMX Secures strategic investment from Gandel Metals at a 33% premium
	Sep 9, 2026 9:19 PM	Join Our Webinar with Whitefield's Angus Gluskie!
	Sep 7, 2026 10:07 PM	EchoIQ FDA Rejection - Read-Through for ASX MedTech